Why choose SCMD?

  • We have extraordinary expertise within our team.
  • We specialise in offering highly sensitive and robust assays which focus on clinically actionable genetic changes. Expensive tests offering very large panels (100’s of genes) often require more tumour sample than is available, and feature many genes for which there are no associated therapies.
  • Our laboratory is a partnership between:
Sarah Cannon

Sarah Cannon

HCA’s global Cancer Institute. Its research arm not only focuses on advancing therapies for patients, but is one of the world’s leading clinical research organisations conducting clinical trials. Sarah Cannon has been a clinical trial leader in the majority of cancer therapies over the last 10 years.

HCA People

HCA Healthcare

An international healthcare company with access to world-class resources and research power, supporting thousands of patients across the US and UK.


Our Genomics Review Board

We are also supported by a team of expert scientists and clinicians who help HCA clinicians interpret and act on our test results.

Find out more about our background and our team.